Stock comparison
ARGENX SE is 2.0x more valuable than BIOGEN INC. by market capitalization ($63.93 B vs $32.60 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ARGX is larger
ARGENX SE is 2.0x more valuable than BIOGEN INC. by market capitalization ($63.93 B vs $32.60 B).
Market value leader
ARGX
ARGENX SE is 2.0x more valuable than BIOGEN INC. by market capitalization ($63.93 B vs $32.60 B).
| Metric | BIIB | ARGX |
|---|---|---|
| Market cap | $32.60 B | $63.93 B |
| US-listed rank | #448 | #263 |
| Revenue (latest FY) | $9.89B | - |
| Net income (latest FY) | $1.29B | - |
| Net margin | 13.1% | - |
| P/E (trailing FY) | 25.2x | - |
| SEC filings | 2,692 | 272 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ARGENX SE is 2.0x more valuable than BIOGEN INC. by market capitalization ($63.93 B vs $32.60 B).
Full pages: BIOGEN INC. and ARGENX SE, or browse the full rankings.